ArticleCancer management and research2025
A Case Report of Pulmonary Malignant Melanoma with Multiple Intracranial Hemorrhagic Metastases.
Article in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary pulmonary malignant melanoma is a very rare non-epithelial tumour with a high degree of malignancy, susceptibility to early haematogenous metastasis and poor prognosis. Lung malignant melanoma with multiple intracranial metastases is highly susceptible to misdiagnosis or underdiagnosis in clinical practice. This article reports a case of pulmonary malignant melanoma with multiple intracranial hemorrhagic metastases, aiming to improve clinicians' understanding of this disease through this case analysis. Especially for patients over 60 years old with intracranial multiple hemorrhage, it is necessary to broaden the diagnostic and therapeutic thinking, and to exclude rare malignant tumors in the whole body through multi-systematic examination, so as to avoid misdiagnosis or omission of the diagnosis, which may cause delays in the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.